跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,312 条关于
“ER/PR”
全部
2,312
临床试验
1,507
药物
277
机构
8
资讯
520
去年
NPPA Committee Identifies Patent Discrepancies in Intas' Clozapine ER Pricing Application
去年
Elacestrant Plus Abemaciclib Shows Promise in Pretreated ER+/HER2- Metastatic Breast Cancer
去年
Trevi Therapeutics Presents Nalbuphine ER Data at Major Respiratory Conferences Following Positive Phase 2 Trials
2年前
FDA Grants Fast Track Designation to Vepdegestrant for ER+/HER2- Metastatic Breast Cancer
去年
Novel ctDNA Assay Shows High Predictive Value for Breast Cancer Recurrence During Neoadjuvant Therapy
10个月前
Life Biosciences Appoints Veteran Biotech Leader David Guyer to Board as Company Prepares for First Human Trials
去年
Life Biosciences Partners with Singapore Institute to Advance Epigenetic Therapies for Age-Related Diseases
去年
Imlunestrant Shows Promise in Advanced ER+/HER2- Breast Cancer Treatment
去年
Novel Therapies to Watch in 2025: Oncology, Hematology, and Neurology
9个月前
HER2-Negative Breast Cancer Pipeline Expands with 75+ Therapies from 70+ Companies
第 1 页,共 52 页
上一页
下一页